Global Travel Vaccines Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection. The report is about 84 pages published in March-2015.
Analysts forecast the Global Travel Vaccines market to grow at a CAGR of 7.78 percent over the period 2014-2019. Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or through injections in both adults and children. Government bodies such as the CDC and the NHS have mandated the vaccination of emigrants traveling to disease-prone areas to prevent the spread of infectious agents through them.
Covered in this Report Based on composition, the Global Travel Vaccines market is divided into two segments: Mono Vaccines and Combination Vaccines. This report covers the present scenario and the growth prospects of the Global Travel Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sale of various vaccines administered to actively immunize against meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Travel Vaccines market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report Global Travel Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Travel Vaccines market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Buy Report @ http://www.sandlerresearch.org/purchase?rname=33179 .
Key Regions Americas APAC
EMEA
Key Vendors GlaxoSmithKline Merck & Co. Novartis Sanofi Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=33179 .
Other Prominent Vendors Beijing Minhai Biotechnology Bharat Biotech Bio Med Crucell CSL Dynavax Technologies Emergent Biosolutions Green Signal Bio Pharma Hualan Biological Engineering Imunoloski Zavod Indian Immunologicals Janssen Pharmaceuticals JN International Medical Kaketsuken
LG Life Sciences Novavax Nuron Biotech Panacea Biotec Pfizer S K Chemicals Serum Institute of India Shenzhen Kangtai Biological Products Sinovac Biotech Vacunas Finlay Valneva
Market Driver Growing Demand among Travelers Market Challenge Cold Chain Management Market Trend Increased Awareness.
Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth?
Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-beforebuying?rname=33179 .
List of Exhibits: Exhibit 1: Market Research Methodology Exhibit 2: Vaccine Approval Process Exhibit 3: Global Travel Vaccines Market 2014-2019 (US$ million) Exhibit 4: Global Hepatitis A Vaccines Market 2014-2019 (US$ million) Exhibit 5: Market Share of the Different Type of Travel Vaccines, 2014 (in percentage) Exhibit 6: Global Travel Vaccines Market Segmentation by Composition Exhibit 7: Segmentation of Global Travel Vaccines Market by Geography 2014 Exhibit 8: SWOT Analysis: Global Travel Vaccines Market 2015-2019 Exhibit 9: GlaxoSmithKline: Revenue 2013 Exhibit 10: GlaxoSmithKline: Vaccine Pipeline Exhibit 11: Merck: Revenue 2013 Exhibit 12: Novartis: Revenue 2013 Exhibit 13: Novartis: Vaccine Pipeline Exhibit 14: Sanofi: Revenue 2013 Exhibit 15: GlaxoSmithKline: Business Segmentation 2013 Exhibit 16: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion) Exhibit 17: GlaxoSmithKline: Sales by Geography 2013
Exhibit 18: GlaxoSmithKline: Pipeline Products 2013 Exhibit 19: Merck & Co. Inc.: Business Segmentation by Revenue 2013 Exhibit 20: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion) Exhibit 21: Merck & Co. Inc.: Sales by Geography 2013 Exhibit 22: Novartis AG: Business Segmentation Exhibit 23: Novartis AG: Revenue by Business Segmentation 2013 Exhibit 24: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million) Exhibit 25: Novartis AG: Revenue by Geographical Segmentation 2013 Exhibit 26: Sanofi SA: Business Segmentation Exhibit 27: Sanofi SA: Revenue by Business Segmentation 2013 Exhibit 28: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million) Exhibit 29: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
Complete Report is Available @ http://www.sandlerresearch.org/global-travel-vaccines-market2015-2019.html .
Browse All Reports on Automotive Market Global Travel Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on “Global Travel Vaccines Market 2015-2019� report OR for any other market research and intelligence needs you may have for your business.